DVBCWLL7 ;ALB/RLC LIVER, GALL BLADDER AND PANCREAS WKS TEXT - 1 ; 12 FEB 2007
;;2.7;AMIE;**121**;Apr 10, 1995;Build 9
;
;
TXT ;
;;C. Physical Examination (Objective Findings):
;;
;;Address each of the following as appropriate, and fully describe current
;;findings:
;;
;; 1. Abdominal Exam
;;
;; a. Describe any areas of tenderness and/or organomegaly, including liver
;; size and whether it is tender to palpation.
;; b. Presence or absence of ascites
;; c. Evidence of Portal Hypertension (e.g. superficial abdominal veins,
;; splenomegaly, abdominal pain)
;;
;; 2. General exam
;;
;; a. Describe all other signs of liver disease (e.g. jaundice, palmar
;; erythema, spider angiomata).
;; b. Evidence of Malnutrition (e.g. muscle wasting)
;;
;;D. Diagnostic and Clinical Tests:
;;
;; 1. For esophageal varices, X-ray, endoscopy, etc.
;;
;; 2. For gall bladder disease, X-ray or other objective confirmation.
;;
;; 3. For liver disease:
;;
;; a. serologic tests for hepatitis as appropriate (e.g. HbsAg,
;; anti-HCV, anti-HBc, ferritin, alpha-fetoprotein); liver imaging
;; as appropriate, (e.g. ultrasound or abdominal CT scan), biopsy
;; report (when available).
;;
;; b. Viral hepatitis (including Hepatitis C): Name the specific type
;; (A, B, C, or other). For hepatitis B and / or hepatitis C,
;; provide an opinion as to which risk factor is the most likely
;; cause, and whether these risk factors were present during the
;; veteran's time in the military. Please support your opinion by
;; discussing all risk factors in the individual and your rationale
;; for your opinion. If you cannot determine which risk factor is
;; the likely cause, state that there is no risk factor that is
;; more likely than another to be the cause, and explain.
;;
;; c. Hepatitis C: Please note that Hepatitis C generally does not
;; produce clinically evident hepatitis at the time of infection.
;; Please provide results of serologic (anti-HCV antibody) and
;; viral (HCV RNA) testing for hepatitis C. The anti-HCV assay
;; confirms exposure to hepatitis C but does not differentiate
;; between chronic, acute, or resolved infection. False positive
;; and false negative results occur, but rarely. A positive
;; qualitative or quantitative HCV RNA assay indicates current
;; hepatitis C infection. A negative qualitative HCV RNA assay
;; indicates that the individual does not have active, chronic
;; hepatitis C. The recombinant immunoblot assay (RIBA) is a
;; confirmatory serologic test that establishes the diagnosis of
;; past (resolved) infection if the anti-HCV is positive but the
;; HCV RNA assay is negative.
;;
;;The following are established risk factors for acquisition of hepatitis C
;;infection:
;;
;; -Blood transfusion before 1992
;; -Past or present intravenous drug use
;; -Blood exposure of skin or mucous membranes including accidental needle
;; punctures
;; -Sexual transmission (though most studies have failed to identify sexual
;; transmission of this agent). Sexual transmission appears to be confined
;; to such subgroups as persons with multiple sexual partners and sexually
;; transmitted diseases.
;; -History of hemodialysis
;; -Tattoo or repeated body piercing
;; -History of intranasal cocaine use
;;
;;See Harrison's Principles of Internal Medicine, 15th edition, The McGraw Hill
;;Companies, Inc., page 1709, 1729-1730.
;;
;;Please consider the veteran's potential for skin and mucous membrane exposure
;;to blood, especially where the veteran was a military corpsman, a medical
;;worker, or a combat veteran.
;;
;; d. Cirrhosis, chronic hepatitis, liver malignancy, or other chronic
;; liver disease: State the most likely etiology. Address the
;; relationship of the disease to active service, including any
;; hepatitis that occurred in service.
;;
;; 4. Include results of all diagnostic and clinical tests conducted in the
;; examination report.
;;
;;E. Diagnosis:
;;
;;
;;
;;Signature: Date:
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HDVBCWLL7 4494 printed Dec 13, 2024@01:52:19 Page 2
DVBCWLL7 ;ALB/RLC LIVER, GALL BLADDER AND PANCREAS WKS TEXT - 1 ; 12 FEB 2007
+1 ;;2.7;AMIE;**121**;Apr 10, 1995;Build 9
+2 ;
+3 ;
TXT ;
+1 ;;C. Physical Examination (Objective Findings):
+2 ;;
+3 ;;Address each of the following as appropriate, and fully describe current
+4 ;;findings:
+5 ;;
+6 ;; 1. Abdominal Exam
+7 ;;
+8 ;; a. Describe any areas of tenderness and/or organomegaly, including liver
+9 ;; size and whether it is tender to palpation.
+10 ;; b. Presence or absence of ascites
+11 ;; c. Evidence of Portal Hypertension (e.g. superficial abdominal veins,
+12 ;; splenomegaly, abdominal pain)
+13 ;;
+14 ;; 2. General exam
+15 ;;
+16 ;; a. Describe all other signs of liver disease (e.g. jaundice, palmar
+17 ;; erythema, spider angiomata).
+18 ;; b. Evidence of Malnutrition (e.g. muscle wasting)
+19 ;;
+20 ;;D. Diagnostic and Clinical Tests:
+21 ;;
+22 ;; 1. For esophageal varices, X-ray, endoscopy, etc.
+23 ;;
+24 ;; 2. For gall bladder disease, X-ray or other objective confirmation.
+25 ;;
+26 ;; 3. For liver disease:
+27 ;;
+28 ;; a. serologic tests for hepatitis as appropriate (e.g. HbsAg,
+29 ;; anti-HCV, anti-HBc, ferritin, alpha-fetoprotein); liver imaging
+30 ;; as appropriate, (e.g. ultrasound or abdominal CT scan), biopsy
+31 ;; report (when available).
+32 ;;
+33 ;; b. Viral hepatitis (including Hepatitis C): Name the specific type
+34 ;; (A, B, C, or other). For hepatitis B and / or hepatitis C,
+35 ;; provide an opinion as to which risk factor is the most likely
+36 ;; cause, and whether these risk factors were present during the
+37 ;; veteran's time in the military. Please support your opinion by
+38 ;; discussing all risk factors in the individual and your rationale
+39 ;; for your opinion. If you cannot determine which risk factor is
+40 ;; the likely cause, state that there is no risk factor that is
+41 ;; more likely than another to be the cause, and explain.
+42 ;;
+43 ;; c. Hepatitis C: Please note that Hepatitis C generally does not
+44 ;; produce clinically evident hepatitis at the time of infection.
+45 ;; Please provide results of serologic (anti-HCV antibody) and
+46 ;; viral (HCV RNA) testing for hepatitis C. The anti-HCV assay
+47 ;; confirms exposure to hepatitis C but does not differentiate
+48 ;; between chronic, acute, or resolved infection. False positive
+49 ;; and false negative results occur, but rarely. A positive
+50 ;; qualitative or quantitative HCV RNA assay indicates current
+51 ;; hepatitis C infection. A negative qualitative HCV RNA assay
+52 ;; indicates that the individual does not have active, chronic
+53 ;; hepatitis C. The recombinant immunoblot assay (RIBA) is a
+54 ;; confirmatory serologic test that establishes the diagnosis of
+55 ;; past (resolved) infection if the anti-HCV is positive but the
+56 ;; HCV RNA assay is negative.
+57 ;;
+58 ;;The following are established risk factors for acquisition of hepatitis C
+59 ;;infection:
+60 ;;
+61 ;; -Blood transfusion before 1992
+62 ;; -Past or present intravenous drug use
+63 ;; -Blood exposure of skin or mucous membranes including accidental needle
+64 ;; punctures
+65 ;; -Sexual transmission (though most studies have failed to identify sexual
+66 ;; transmission of this agent). Sexual transmission appears to be confined
+67 ;; to such subgroups as persons with multiple sexual partners and sexually
+68 ;; transmitted diseases.
+69 ;; -History of hemodialysis
+70 ;; -Tattoo or repeated body piercing
+71 ;; -History of intranasal cocaine use
+72 ;;
+73 ;;See Harrison's Principles of Internal Medicine, 15th edition, The McGraw Hill
+74 ;;Companies, Inc., page 1709, 1729-1730.
+75 ;;
+76 ;;Please consider the veteran's potential for skin and mucous membrane exposure
+77 ;;to blood, especially where the veteran was a military corpsman, a medical
+78 ;;worker, or a combat veteran.
+79 ;;
+80 ;; d. Cirrhosis, chronic hepatitis, liver malignancy, or other chronic
+81 ;; liver disease: State the most likely etiology. Address the
+82 ;; relationship of the disease to active service, including any
+83 ;; hepatitis that occurred in service.
+84 ;;
+85 ;; 4. Include results of all diagnostic and clinical tests conducted in the
+86 ;; examination report.
+87 ;;
+88 ;;E. Diagnosis:
+89 ;;
+90 ;;
+91 ;;
+92 ;;Signature: Date: